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Research
Environmental factors influencing the 
  developmental origins of health and dis-
ease need to be identified and investigated 
(Swanson et al. 2009). To this end, charac-
terizing the relation of in utero exposure to 
tobacco smoke to subsequent health out-
comes will serve as an important benchmark. 
Maternal smoking during pregnancy has a 
number of well-known short-term adverse 
effects on offspring, such as shortened ges-
tation and fetal growth restriction [Centers 
for Disease Control and Prevention (CDC) 
2002]. Recent findings suggest that exposure 
to maternal smoking may also have long-term 
health consequences. Exposure to tobacco 
smoke in utero has been associated in infants 
with alterations of blood pressure control 
mechanisms (Cohen et al. 2010), and in chil-
dren with an increase in blood pressure (BP) 
(Brion et al. 2008) and with overweight and 
obesity (Ino 2010; Oken et al. 2008). During 
adulthood, the association of obesity with 
in utero exposure to tobacco smoke persists 
(Power and Jefferis 2002); however, it is not 
clear whether such exposure is associated with 
adult diabetes or hypertension (Power et al. 
2010; Thomas et al. 2007). Among adults, 
other adverse outcomes such as carotid wall 
thickening (Geerts et al. 2008) and raised cho-
lesterol (Jaddoe et al. 2008) have also been 
linked to in utero exposure to tobacco smoke.
Recent evidence suggests that altera-
tions in fetal programming, in response to an 
adverse fetal environment, might be involved 
in the origins of chronic conditions later in life 
(Gluckman and Hanson 2004). In addition, 
experiments conducted in rodents support an 
association between fetal nicotine exposure 
and adverse effects in the offspring such as 
obesity, increased blood pressure, and altered 
glucose homeostasis (Bruin et al. 2010). 
Nevertheless, epidemiologic studies evaluating 
analogous outcomes during adulthood in rela-
tion to in utero tobacco smoke are scarce.
We evaluated the association of self-
  reported in utero exposure to maternal tobacco 
smoke (i.e., exposure 14–47 years ago for 
women enrolled in the present study) with 
the prevalence of prepregnancy obesity, hyper-
tension, and type 2 diabetes mellitus (T2DM) 
in a cohort of pregnant women. We also evalu-
ated the association of self-reported in utero 
exposure to tobacco smoke with prevalence 
of gestational diabetes mellitus (GDM). 
GDM and T2DM have somewhat similar 
patho  physiologies (Buchanan et al. 2007), 
and women with GDM are at increased risk 
of developing T2DM (Kim et al. 2002). To 
our knowledge, GDM has not been previously 
examined in relation to in utero tobacco smoke.
Materials and Methods
This study was based on the Norwegian 
Mother and Child Cohort Study (MoBa) 
conducted by the Norwegian Institute of 
Public Health (Magnus et al. 2006). MoBa is 
a cohort based on 108,000 pregnancies from 
90,700 women enrolled from 1999 through 
2008. Some women in the cohort partici-
pated with more than one pregnancy. Most 
pregnant women in Norway were invited to 
participate, and 38.5% of invited women 
participated in the study. Participants were 
recruited with a mailed invitation before a 
routine ultrasound examination offered to all 
pregnant women in Norway at 17–18 weeks 
of gestation [Norwegian Institute of Public 
Health (NIPH) 2007]. The study was 
approved by the Regional Committee for 
Medical Research Ethics and the Norwegian 
Data Inspectorate. Informed consent was 
obtained from each participant. At enroll-
ment (~ 17 weeks of gestation), participants 
completed a questionnaire about demograph-
ics, reproductive health, disease and medica-
tion history, and lifestyle. We conducted a 
cross-sectional analysis based on version 5.0 
of the quality-assured data files released for 
research in July 2010. Our analysis was lim-
ited to the woman’s first pregnancy in MoBa.
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Ba c k g r o u n d: Environmental factors influencing the developmental origins of health and disease 
need to be identified and investigated. In utero exposure to tobacco smoke has been associated with 
obesity and a small increase in blood pressure in children; however, whether there is a corresponding 
increased risk of conditions such as diabetes and hypertension during adulthood remains unclear.
oB j e c t i v e: Our goal was to assess the association of self-reported in utero exposure to tobacco 
smoke with the prevalence of obesity, hypertension, type 2 diabetes mellitus (T2DM), and gesta-
tional diabetes mellitus (GDM) in women 14–47 years of age.
Me t h o d s : We conducted a cross-sectional analysis of the Norwegian Mother and Child Cohort 
Study, which enrolled pregnant women in Norway from 1999 thorough 2008. Exposure to tobacco 
smoke in utero (yes vs. no) was ascertained on the baseline questionnaire (obtained at ~ 17 weeks’ 
gestation); the outcomes were ascertained from the Medical Birth Registry of Norway and the ques-
tionnaire. Our analysis included 74,023 women.
re s u l t s: Women exposed to tobacco smoke in utero had 1.53 times the odds of obesity [95% con-
fidence interval (CI): 1.45, 1.61] relative to those unexposed, after adjusting for age, education, and 
personal smoking. After further adjustment for body mass index, the odds ratio for hypertension 
was 1.68 (95% CI: 1.19, 2.39); for T2DM 1.14 (95% CI: 0.79, 1.65); and for GDM 1.32 (95% 
CI: 1.10, 1.58) among exposed compared with unexposed.
co n c l u s i o n s: Exposure to tobacco smoke in utero was associated with obesity, hypertension, and 
GDM in adult women. The possibility that the associations were attributable to unmeasured con-
founding cannot be excluded.
key w o r d s : diabetes mellitus, gestational diabetes, hypertension, in utero, maternal smoking, 
MoBa, obesity, tobacco smoke. Environ Health Perspect 120:355–360 (2012).  http://dx.doi.
org/10.1289/ehp.1103789 [Online 29 November 2011]Cupul-Uicab et al.
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Exposure assessment. The woman’s own 
exposure to tobacco smoke in utero was ascer-
tained on the baseline questionnaire (Figure 1). 
Women were asked “Did your mother smoke 
when she was pregnant with you?” Those who 
answered “yes” were classified as having been 
exposed to tobacco smoke in utero; those who 
responded “no” were considered unexposed. 
For women with more than one pregnancy in 
the cohort, the consistency of answers across 
pregnancies was verified. In general, if the 
woman gave two different answers in two con-
secutive pregnancies (e.g. yes/no; no/yes; no/
don’t know; yes/don’t know), the response 
was considered inconsistent and the subject 
was excluded from the analysis. However, if 
the first answer was “don’t know” and then 
she gave a different answer after that (yes or 
no), we used the latter under the assumption 
that the woman had asked her mother about 
her exposure in utero. The reported in utero 
exposure to tobacco smoke has been shown 
to be a valid and reproducible measure in 
the MoBa cohort (Cupul-Uicab et al. 2011a, 
2011b). Women were not asked about child-
hood cigarette smoke exposure.
Outcomes. Obesity, hypertension, and 
T2DM before pregnancy, and GDM dur-
ing the MoBa index pregnancy (i.e., the 
woman’s first pregnancy in MoBa) were the 
main outcomes. Obesity was defined as a pre-
pregnancy body mass index (BMI) ≥ 30 kg/m2 
(National Institutes of Health 1998). Height 
and prepregnancy weight were reported by 
the women on the baseline questionnaire. 
Women were classified as hypertensive if 
they met all three of the following criteria: 
a) reported having high blood pressure before 
pregnancy on the baseline questionnaire (“Do 
you have or have you had high blood pressure 
before pregnancy?”); b) reported the use of 
anti  hypertensive medication before pregnancy 
on the baseline questionnaire (“If you have 
taken medication in conjunction with the high 
blood pressure give the names and when you 
took them”); and c) chronic hypertension was 
also reported in the Medical Birth Registry 
of Norway (MBRN; Bergen, Norway). The 
MBRN is a population-based registry that 
contains information on all births in Norway 
since 1967; its data are collected on standard 
antenatal forms completed by midwives or 
doctors. GDM and (pregestational) T2DM 
were ascertained from the MBRN because 
the questions asked in the baseline question-
naire did not differentiate between types of 
diabetes. To support the accuracy of the regis-
try’s assessment of the GDM case status, we 
conducted a validation substudy. Based on the 
MBRN records, we selected 60 women who 
had GDM and 79 women who did not, and 
examined their pregnancy medical records to 
verify the MBRN classification.
Statistical analysis. For the present analysis 
we considered as potentially eligible all women 
with baseline questionnaire and MBRN data 
for the first pregnancy in which they were 
enrolled in MoBa (n = 85,910). Those missing 
data on personal smoking, prepregnancy BMI, 
or education were also excluded (n = 1,544). 
In addition, women were excluded if, for 
in utero tobacco smoke, there were missing 
data, unknown exposure, or inconsistent 
answers (n = 10,343). After all the exclusions, 
74,023 women were included in the analysis 
(Figure 2).
The associations of in utero exposure to 
tobacco smoke with obesity, hypertension, 
T2DM, and GDM were assessed separately 
with logistic regression. Women classified by 
the MBRN with unspecified diabetes before 
or during pregnancy were excluded from 
the analysis of T2DM and GDM. Women 
with GDM were excluded from all T2DM 
analysis, and those with T2DM were excluded 
from all GDM analysis. In addition, women 
were excluded from the GDM analysis if they 
reported the use of any diabetic treatment 
before pregnancy (n = 57) or delivered at 
≤ 20 weeks of gestation (n = 122). All models 
included in utero tobacco smoke as the main 
exposure and were adjusted for woman’s age, 
education, and personal smoking as a priori 
selected variables. Additional variables that were 
associated with any of the outcomes of interest 
in bivariate analyses (p ≤ 0.20) were assessed 
as potential confounders using the change in 
estimate method, starting with all variables 
in the models with deletion of one by one in 
a stepwise manner (Greenland 1989). None 
of the tested variables [i.e., parity, physi  cal 
activity (times/week), and alcohol consumption 
(drinks/week)] caused ≥ 10% change in the 
odds ratio (OR) for in utero smoking in any 
of the models. Income was not included as 
a confounder because of its correlation with 
education (Spearman r = 0.44, p < 0.01) and 
because education was a stronger predictor of 
the exposure than income. Similarly, year of 
birth was not added to the models because of 
Figure 1. Ascertainment of the exposure and outcomes among women from the MoBa cohort. For exam-
ple, women born in 1970 who enrolled in MoBa in 2000 when pregnant (at ~ 17 weeks’ gestation), reported 
their exposure to tobacco smoke when they were in utero 30 years previously. Their outcomes in adult-
hood were reported at enrollment or were ascertained from the MBRN.
1950 1960 1970 1980 1990 2000 2010
Linkage
The MoBa participant’s mother
did or did not smoke when
pregnant with the participant
Obesity, hypertension,
T2DM, and GDM among
MoBa participants
Medical Birth Registry of 
Norway (additional data 
on adult disease)
MoBa participants enrolled and reported their exposure 
(whether her mother did or did not smoke when 
pregnant with her) and adult disease status
Figure 2. Selection of sample for analysis of in utero exposure to maternal tobacco smoke and subsequent 
obesity, hypertension, and gestational diabetes among women in the MoBa cohort.
aBased on data set version 5.0.
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its high correlation with age (Pearson r = –0.90, 
p < 0.01). Additional adjustment for income 
and year of birth was done in a sensitivity 
analysis. BMI is a known risk factor for hyper-
tension, T2DM, and GDM (Li et al. 2007; 
Vazquez et al. 2007; Yeung et al. 2010); 
therefore we present the adjusted ORs before 
and after including BMI in the models. All 
analyses were done using Stata (release 10.1; 
StataCorp, College Station, TX, USA).
Birth weight was considered an inter-
mediate variable [exposure to in utero tobacco 
smoke reduces birth weight (Kramer 1987)]; 
thus, birth weight was included in the models 
only in a sensitivity analysis. The latter 
analysis was conducted among the subset 
of women born in 1967 (when the MBRN 
was established) or later, with available birth 
weight (88% of 70,539).
Because the outcomes of interest were cor-
related, we conducted a number of sensitivity 
analyses to evaluate whether the associations 
seen with in utero tobacco smoke were inde-
pendent. Women with T2DM were excluded 
from the model of obesity. Women with 
T2DM or heart disease before pregnancy were 
excluded from the model of hypertension. 
Women with hypertension, with medication 
for high cholesterol, or with GDM in a previ-
ous pregnancy were excluded from the model 
of T2DM. Women with hypertension or 
GDM in a previous pregnancy were excluded 
from the model of GDM. Excluding women 
with nonconfirmed hypertension [reported 
only in the baseline questionnaire or MBRN 
(n = 351)] did not materially change the associ-
ation with hypertension, so they were included 
in the analyses. Similarly, excluding women 
with type 1 DM (n = 280) did not change the 
associations with T2DM and GDM, so they 
were included in the analyses. In additional 
sensitivity analyses, women with inconsis-
tent answers or unknown exposure to in utero 
tobacco smoke were included in the models 
as a third exposure category because they were 
likely a mix of exposed and unexposed subjects.
Only one subject had obesity, hyper-
tension, and T2DM before pregnancy; 91 had 
two of these conditions. Therefore, we did a 
separate analysis to estimate the OR of having 
at least two of these outcomes versus none. 
Because women exposed to in utero tobacco 
smoke were more likely to smoke as adults, 
and smokers tend to be different from non-
smokers regarding socioeconomic and other 
risk factors (data not shown), multiplica  tive 
interactions between in utero tobacco smoke 
(yes/no) and personal smoking (yes/no) were 
examined in all the models. Interactions 
between the exposure (yes/no) and BMI (con-
tinuous) were also tested in the models for 
hypertension, T2DM, and GDM. An inter-
action was considered important if the p-value 
for the interaction term was ≤ 0.10.
Results
The prevalence of in utero exposure to tobacco 
smoke varied across categories of all variables 
listed in Table 1 (p < 0.05), except for the 
use of medication for high cholesterol, heart 
disease, and T2DM before pregnancy (non-
significant). The highest percentages of in utero 
exposure to tobacco smoke (> 40%) were in 
women < 20 years of age, those with less than 
a high school education, those who smoked 
Table 1. Characteristics of the women according to their in utero exposure to tobacco smoke and BMI. 
p-Values from Pearson’s chi-square or Fisher’s exact test were ≤ 0.01 for all variables listed, except for “Use medication for high cholesterol” (p = 0.17) and “T2DM” (p = 0.07) for 
in utero smoking and “Heart disease” (p = 0.25 for in utero smoking; p = 0.39 for obesity).
aPrepregnancy BMI ≥ 30 kg/m2. bReflects the woman’s exposure 3 months before pregnancy. cOne unit of alcohol is equivalent to 1.5 cL pure alcohol. dWoman’s condition before 
  pregnancy. 
 
Total
Exposed to 
tobacco smoke 
in utero (%)
Prepregnancy 
obesitya (%) Characteristic n (%)
All women 74,023 27.8 9.4
Age (years)
< 20 855 (1.2) 41.8 7.4
20–24 8,079 (10.9) 33.3 10.2
25–29 25,332 (34.2) 28.1 8.8
30–34 27,421 (37.0) 26.9 9.2
35–39 10,846 (14.7) 25.7 10.3
≥ 40  1,490 (2.0) 18.3 12.1
Year of birth
≤ 1965 2,265 (3.1) 20.3 10.7
1966–70 12,063 (16.3) 26.1 10.6
1971–75 26,171 (35.4) 28.1 9.2
1976–80 23,122 (31.2) 27.7 8.8
≥ 1981  10,402 (14.1) 30.9 9.6
Education
< High school 6,120 (8.3) 43.4 14.9
High school 22,144 (29.9) 34.3 12.8
College 29,457 (39.8) 24.7 8.1
> College 16,302 (22.0) 18.9 5.1
Gross income/year (US$)
< 46,270 46,558 (62.9) 29.6 10.6
≥ 46,270  25,306 (34.2) 24.4 7.1
Missing 2,159 (2.9) 29.5 9.4
Parity
0 40,365 (54.5) 25.8 8.5
1 21,781 (29.4) 30.2 10.0
2 9,641 (13.0) 30.1 10.7
≥ 3  2,236 (3.0) 30.9 14.4
Smoking (cigarettes/day)b
None 51,852 (70.0) 23.5 8.8
< 10 12,270 (16.6) 28.5 8.5
≥ 10  9,901 (13.4) 49.6 13.6
 
Total
Exposed to 
tobacco smoke 
in utero (%)
Prepregnancy 
obesitya (%) Characteristic n (%)
Alcohol drinking (units/week)b,c
None 3,315 (4.5) 14.0 9.3
< 1 47,880 (64.7) 28.9 10.9
1.0–3.5 12,060 (16.3) 26.8 6.8
> 3.5 9,838 (13.3) 28.9 5.5
Missing 930 (1.3) 26.0 6.5
Physical activityb (times/week)
None 8,217 (11.1) 31.6 12.1
< 4.0 28,714 (38.8) 29.7 11.9
4.0–7.0 21,476 (29.0) 26.2 7.8
> 7.0 15,616 (21.1) 24.7 5.5
Use medication for high cholesterold
No 73,934 (99.9) 27.8 9.4
Yes 89 (0.1) 21.3 18.0
Heart diseased (MBRN)
No 73,584 (99.4) 27.8 9.4
Yes 439 (0.6) 30.3 8.2
GDM in a previous pregnancy
No 73,549 (99.4) 27.8 9.3
Yes 474 (0.6) 39.0 23.0
Prepregnancy BMI (kg/m2)
≤ 18.5 2,453 (3.3) 24.4
18.6 – < 25.0 48,485 (65.5) 25.0
25.0 – < 30.0 16,133 (21.8) 32.3
≥ 30.0  6,952 (9.4) 38.6 100.0
Hypertensiond
No 73,887 (99.8) 27.8 9.3
Yes 136 (0.2) 41.9 33.8
T2DMd
No 73,249 (99.0) 27.7 9.1
Yes 132 (0.2) 34.8 34.8
GDM in current pregnancy
No 73,105 (98.8) 27.7 9.1
Yes 547 (0.7) 38.0 32.0Cupul-Uicab et al.
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≥ 10 cigarettes/day in the 3 months before the 
index pregnancy, and those with hyper  tension 
before pregnancy. The highest prevalence 
of obesity (≥ 23%) was in women who had 
hypertension, T2DM, or GDM (Table 1). The 
most frequent outcome was obesity (9.4%); 
lower prevalence was observed for hypertension 
(0.2%), T2DM (0.2%), and GDM (0.7%) 
(Table 1). The participants’ mean age (± SD) 
was 30 ± 4.7 years (range, 14–47 years).
Among women with a diagnosis of GDM 
in the MBRN, 88.3% were validated against 
the pregnancy medical records; and among 
those without a diagnosis of GDM in the 
MBRN record, none was classified with GDM 
by the medical records.
As expected, women with hypertension, 
T2DM, or GDM had higher BMIs com-
pared with noncases (Table 2). Compared 
with unexposed women, those exposed to 
in utero tobacco smoke were more likely, 
before the pregnancy, to have had obesity 
[adjusted OR (aOR) = 1.53; 95% confidence 
interval (CI): 1.45, 1.61], hypertension (aOR 
= 1.97; 95% CI: 1.39, 2.80), and T2DM 
(aOR = 1.33; 95% CI: 0.92, 1.93), though 
the latter did not reach statistical significance. 
Exposed women were also more likely to 
develop GDM in the MoBa pregnancy (aOR 
= 1.52; 95% CI: 1.28, 1.82) (Table 2). ORs 
adjusted for age only were 0–10% higher than 
unadjusted estimates (data not shown). After 
further adjustment for BMI, ORs for hyper-
tension, T2DM, and GDM were attenuated 
(Table 2); however, the associations of in utero 
exposure to tobacco smoke with hypertension 
and GDM were still evident.
Among women with available birth weight 
(Table 3), the association of in utero smok-
ing with obesity, hypertension, and GDM 
remained before and after adjusting for birth 
weight and gestational age. The associations 
were similar when we restricted the analysis to 
women born at term (Table 3).
The results from Table 2 remained essen-
tially the same after additional adjustment 
for income and year of birth; after excluding 
women with T2DM from the final model of 
obesity; after excluding women with T2DM 
or heart disease before pregnancy from the 
final model of hypertension (with BMI); after 
excluding women with hypertension, those 
with medication for high cholesterol, or GDM 
in a previous pregnancy (n = 356) from the 
final model of T2DM (with BMI); and after 
excluding women with hypertension from the 
final model of GDM (with BMI) (data not 
shown). When women with GDM in a previ-
ous pregnancy were excluded from the final 
model of GDM (with BMI), the adjusted OR 
for in utero smoking was similar (aOR = 1.35; 
95% CI: 1.11, 1.64) to the aOR (with BMI) 
from Table 2. Compared with unexposed 
women, those with unknown or uncertain 
exposure to in utero tobacco smoke were also 
more likely to be obese (aOR = 1.33; 95% CI: 
1.24, 1.43) and to have hypertension (aOR 
with BMI = 1.79; 95% CI: 1.14, 2.80), but 
were similar with regard to T2DM (aOR with 
BMI = 1.08; 95% CI: 0.65, 1.81) and GDM 
(aOR with BMI = 1.10; 95% CI: 0.85, 1.42).
Women exposed to tobacco smoke in utero 
were two times more likely to have at least 
two of the outcomes (obesity, hypertension, or 
T2DM) before pregnancy (aOR = 2.13; 95% 
CI: 1.39, 3.28) compared with nonexposed; 
adjusting for birth weight and gestational age 
gave similar results (aOR = 2.31; 95% CI: 
1.40, 3.82). A statistically significant interaction 
between in utero exposure to tobacco smoke 
and adult smoking was observed only in the 
model for obesity (Table 4). In utero tobacco 
smoke was a stronger predictor of obesity 
among women who were nonsmokers (aOR 
= 1.75; 95% CI: 1.64, 1.87) as adults than 
among smokers (aOR = 1.29; 95% CI: 1.18, 
1.40; p-interaction < 0.01). We also observed 
stronger associations of in utero exposure to 
tobacco smoke with hypertension, T2DM, 
and GDM among smokers than among non-
smokers. Interactions between in utero smoking 
and BMI were not observed for hypertension, 
T2DM, and GDM (p-interaction > 0.30).
Discussion
Women exposed to tobacco smoke in utero 
were more likely as adults to be obese and 
have hypertension. For T2DM we observed 
slightly increased odds, however, the results 
were not statistically significant. The odds 
of developing GDM in pregnancy were also 
increased in women exposed to tobacco 
smoke in utero; to our knowledge this associa-
tion has not been examined previously. Our 
results were similar after adjusting for birth 
weight and concurrent BMI.
In animals, fetal nicotine exposure results 
in increased adiposity and body weight, 
Table 2. ORs for obesity, hypertension, T2DM, and GDM by in utero exposure to tobacco smoke among 
adult women.
Noncasesa Casesa Unadjusted
Adjustedb 
(no BMI)
Adjustedb 
(with BMI)
Outcomes BMI Median (IQR) BMI Median (IQR) OR (95% CI) OR (95% CI) OR (95% CI)
Before pregnancy
Obesity 22.7 (3.9) 32.7 (4.1) 1.72 (1.63, 1.81) 1.53 (1.45, 1.61)
Hypertension 23.0 (4.7) 26.3 (9.2) 1.87 (1.33, 2.64) 1.97 (1.39, 2.80) 1.68 (1.19, 2.39)
Type 2 DM 23.0 (4.7) 27.5 (8.5) 1.39 (0.97, 2.00) 1.33 (0.92, 1.93) 1.14 (0.79, 1.65)
Gestational DM 23.0 (4.7) 27.1 (7.6) 1.60 (1.35, 1.90) 1.52 (1.28, 1.82) 1.32 (1.10, 1.58)
IQR, interquartile range.
aNumbers of noncases and cases: obesity, 67,071 and 6,952; hypertension, 73,887 and 136; T2DM, 73,249 and 132; GDM, 
73,105 and 547. bAdjusted for woman’s age, education, and number of cigarettes smoked before pregnancy; the GDM 
model was adjusted for smoking during pregnancy
Table 3. aORsa for obesity, hypertension, T2DM, and GDM by in utero exposure to tobacco smoke among 
adult women with available birth weight.
All births (n = 61,914) Term birthsb (n = 59,477)
Before adjusting 
for birth weight
Adjusted for 
birth weightc
Adjusted for 
birth weight
Outcomes Cases aOR (95% CI) aOR (95% CI) Cases aOR (95% CI)
Before pregnancy
Obesity 5,927 1.51 (1.43, 1.60) 1.59 (1.50, 1.69) 5,656 1.60 (1.51, 1.70)
Hypertension 104 1.74 (1.17, 2.59) 1.67 (1.11, 2.51) 102 1.67 (1.10, 2.52)
T2DM 94 1.36 (0.89, 2.08) 1.17 (0.76, 1.80) 90 1.13 (0.72, 1.76)
GDM 428 1.49 (1.22, 1.81) 1.39 (1.14, 1.71) 403 1.38 (1.12, 1.70)
aAdjusted for woman’s age, education, and number of cigarettes smoked before pregnancy. The GDM model was 
adjusted for smoking during pregnancy. All models except for obesity were also adjusted for prepregnancy BMI (kg/m2). 
bGestational age ≥ 37 weeks at birth. cAdditionally adjusted for participant’s gestational age at birth.
Table 4. aORsa for obesity, hypertension, T2DM, and GDM by in utero exposure to tobacco smoke among 
women, stratified by adult smoking.b
Nonsmokers (n = 51,852) Smokers (n = 22,171)
Outcomes Cases aOR (95% CI) Cases aOR (95% CI) p-Interactionc
Before pregnancy
Obesity 4,565 1.75 (1.64, 1.87) 2,387 1.29 (1.18, 1.40) < 0.01
Hypertension 105 1.48 (0.98, 2.23) 31 2.56 (1.23, 5.33) 0.24
T2DM 91 1.02 (0.64, 1.62) 41 1.38 (0.74, 2.56) 0.38
GDM 385 1.25 (1.00, 1.55) 162 1.48 (1.08, 2.02) 0.33
aAdjusted for woman’s age and education. All models except for obesity were also adjusted for prepregnancy BMI (kg/m2).   
bAll models except for GDM were stratified by adult smoking before pregnancy; GDM model was stratified by adult 
smoking during pregnancy (n = 55,402 for nonsmokers and n = 18,250 for smokers). cInteraction term between in utero 
tobacco smoke (yes/no) and adult smoking (yes/no).In utero tobacco smoke and adult adverse events
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altered perivascular adipose tissue composition 
and function, raised blood pressure, elevated 
fasting serum insulin concentrations, and 
enhanced insulin response to a glucose chal-
lenge (Bruin et al. 2010). These changes may 
have long-lasting adverse effects in the exposed 
offspring. The doses of nicotine used in ani-
mal experiments results in serum cotinine lev-
els (136 ng/ml) (Bruin et al. 2010) that are 
comparable to those found among moder-
ate smokers (Eskenazi and Bergmann 1995). 
In humans, other less studied constituents of 
tobacco smoke (Bruin et al. 2010) might also 
contribute to the adverse outcomes observed.
An association of in utero exposure to 
tobacco smoke with subsequent childhood obe-
sity has been consistently observed (Oken et al. 
2008). Results from a birth cohort showed that 
this association became stronger with age (up 
to 33 years), and seemed to be independent of 
early-life and other adult confounding factors 
(Power et al. 2010). Results from other stud-
ies, however, raise the possibility that the asso-
ciation may be confounded by social factors 
(Iliadou et al. 2010; Leary et al. 2006).
A previous meta-analysis showed a small 
increase in BP (adjusted β = 0.62 mmHg; 
95% CI: 0.19, 1.05) among children and 
adolescents exposed to tobacco smoke in utero 
(Brion et al. 2008). However, among adults 
(~ 45 years of age) this finding tended to be 
null after accounting for life-time confound-
ing factors (Power et al. 2010).
In studies of in utero tobacco smoke and 
T2DM or elevated percentage of glycosylated 
hemoglobin, the association was gone after 
accounting for adult adiposity and other life-
time confounding factors (Power et al. 2010; 
Thomas et al. 2007). Similarly, our results 
suggested an association between in utero 
tobacco smoke and T2DM; we also observed 
an attenuation of the OR after adjusting for 
adult BMI.
In utero tobacco smoke was not associ-
ated with cardiovascular risk factors other than 
obesity in a recent study (Power et al. 2010). 
However, in another study parental smok-
ing during childhood (a surrogate for in utero 
exposure), was associated with a higher prev-
alence of metabolic syndrome (Hunt et al. 
2006). [Metabolic syndrome is diagnosed 
when at least three of the following condi-
tions are present: central obesity, elevated tri-
glycerides, reduced high-density lipoprotein 
cholesterol, high blood pressure, and elevated 
fasting glucose (Alberti et al. 2009).] We did 
not evaluate metabolic syndrome as an out-
come, although women exposed to tobacco 
smoke in utero were more likely to have at 
least two of the prepregnancy outcomes stud-
ied. Obesity, hypertension, and T2DM are 
chronic conditions that become more preva-
lent at older ages (Deshpande et al. 2008; Ong 
et al. 2007; Pi-Sunyer 2002); as this cohort 
ages, the associations we observed may be esti-
mated more precisely, perhaps becoming easier 
to detect as more women develop the out-
comes of interest. The association of in utero 
exposure to tobacco smoke with GDM may 
also have implications for future evaluations 
of the association between in utero exposure 
to tobacco smoke and T2DM (GDM is a risk 
factor for T2DM).
The prevalence of obesity and T2DM 
tends to be slightly higher in women than in 
men, while the prevalence of hypertension in 
early adulthood tends to be higher in men than 
in women (American Diabetes Association 
2010; Chobanian et al. 2003; Pi-Sunyer 2002). 
Differences between the sexes were not reported 
in most previous studies of in utero exposure to 
tobacco smoke (Hunt et al. 2006; Power et al. 
2010; Thomas et al. 2007). The association of 
in utero exposure to tobacco smoke with obe-
sity was, however, slightly stronger among men 
in one study (Power and Jefferis 2002). Thus, 
our results may not be generalizable to males.
In the present study and previous studies, 
many factors (e.g., social, demographic, and 
lifestyle) were associated with in utero tobacco 
smoke; thus, confounding by unmeasured fac-
tors may explain some or all of the associations 
we identified (Donovan and Susser 2011). And 
many examples exist where once confound-
ing by lifetime factors is accounted for, the 
relationship weakens. However, adjustment 
for risk factors that are affected by the exposure 
(i.e., birth weight and BMI) is controversial 
because standard methods used to assess the 
direct effect of an exposure on a given outcome 
after controlling for an intermediate variable 
may result in bias (Cole and Hernan 2002). 
In some studies, father’s smoking is as strongly 
associated with total fat mass and blood pres-
sure in children as is mother’s smoking, which 
has been interpreted as evidence of confound-
ing (Brion et al. 2007; Leary et al. 2006). 
However, among pregnant women exposed to 
secondhand tobacco smoke, levels of cotinine 
(the primary metabolite of nicotine) in fetal 
fluids can be higher than those found in mater-
nal serum (Jauniaux et al. 1999). Thus, in utero 
exposure to tobacco smoke from the partner 
may truly have an impact on the fetus.
The estimation of a controlled direct effect 
of in utero exposure to tobacco smoke on the 
outcomes (i.e., obesity, hypertension, T2DM, 
and GDM) would have required the use of 
causal methods and assumptions that do not 
necessary hold in the present setting (Cole 
and Hernan 2002); therefore, we used a tra-
ditional approach. In our analyses adjusted 
for potential intermediate variables (e.g., 
BMI), we are implicitly assuming that there 
are no unmeasured common causes of the 
inter  mediate variable and the outcomes (i.e., 
hypertension, T2DM, and GDM), which is 
also a questionable assumption.
Our stratified analysis showed somewhat 
stronger associations of in utero exposure to 
tobacco smoke with hypertension, T2DM, 
and GDM among smokers than among non-
smokers, but a stronger association with obe-
sity among nonsmokers than among smokers. 
A potential explanation for the weaker asso-
ciation with obesity among smokers is that 
women who smoke tend to gain less weight as 
they age than do nonsmokers (CDC 2002) or 
perhaps because the “effect” of in utero expo-
sure to tobacco smoke is additive (i.e., smokers 
may have other adverse exposures or behaviors 
related to their smoking and positively associ-
ated with obesity, thus in utero smoking has 
little “effect” on their outcome).
Our results were derived from a cross-
sectional analysis of self-reported early-life 
exposure to tobacco smoke and adult adverse 
outcomes. Women were unaware of the study 
hypothesis, so differential reporting of out-
comes by exposure status seems unlikely.
Women reported their own in utero expo-
sure to tobacco smoke 14–47 years later. 
Random errors in the classification of the expo-
sure might have occurred, causing an underes-
timation of the ORs. The reported exposure to 
maternal tobacco smoke in utero by the adult 
offspring has been shown to be valid and repro-
ducible (Cupul-Uicab et al. 2011a, 2011b; 
Simard et al. 2008). In MoBa, the validity of 
the exposure was assessed indirectly using the 
birth weights of a subset of participants. In gen-
eral, maternal smoking during pregnancy has 
been associated with an average reduction of 
149 g in birth weight (Kramer 1987); among 
MoBa participants the observed reduction was 
181 g (Cupul-Uicab et al. 2011b). The repro-
ducibility of self-reported in utero exposure to 
tobacco smoke in MoBa was high (weighted κ 
= 0.80) (Cupul-Uicab et al. 2011b). The inten-
sity of in utero exposure to tobacco smoke was 
not ascertained in MoBa; therefore we could 
not evaluate a dose–response relationship. If 
women who experienced very intense exposure 
to maternal tobacco smoke in utero were under-
represented in our study, we may have under-
estimated the ORs. Information on in utero 
exposure tobacco smoke by trimester as well as 
the number of mothers who stopped smoking 
during pregnancy was not ascertained, limiting 
our ability to assess critical windows of expo-
sure. We were unable to discriminate between 
in utero tobacco smoke and childhood expo-
sure; however, it is likely that women whose 
mothers smoked while pregnant with them 
(i.e., exposed in utero) also experienced con-
tinuous exposure during childhood (Weinberg 
et al. 1989). Information on childhood expo-
sure to tobacco smoke from both parents as 
well as paternal smoking during the mother’s 
pregnancy was not ascertained in MoBa. Thus, 
confounding by childhood exposure to tobacco 
smoke from parents cannot be ruled out.Cupul-Uicab et al.
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The outcomes studied were questionnaire-
based or ascertained from the MBRN; how-
ever, we were able to assess the validity of the 
GDM within the MoBa cohort. The positive 
predictive value (88%) of the MBR against 
medical records in the present study was similar 
to what was reported previously for the MBRN 
in 1998 (89%, validated against medical 
records) before changes were introduced to the 
MBRN form (Stene et al. 2007). Self-reported 
height and weight give accurate estimates of 
BMI among adults (Brunner Huber 2007); 
and agreement of medical records with self-
reported hypertension and diabetes in other 
populations has been moderate to high (Okura 
et al. 2004). In addition, known predictors 
of the outcomes were confirmed in the pres-
ent study. For example, BMI was negatively 
associated with education (Table 1); hyper-
tension and diabetes (T2DM and GDM) were 
positively associated with prepregnancy BMI 
(data not shown). In utero exposure to smoking 
was not associated with type 1 diabetes mellitus 
(data not shown), further supporting the speci-
ficity and validity of the diabetes outcomes. 
Nonetheless, random errors in the classification 
of the outcomes may have occurred, leading to 
an underestimation of the associations.
Women who participated in MoBa are not 
a representative sample of pregnant women 
from Norway; the prevalence of exposures and 
outcomes were biased. For example, the preva-
lence of smoking at the end of the pregnancy 
in Norway was 10.8% (MBRN; between 2000 
and 2006) and the corresponding prevalence 
in MoBa was 6.1% (Nilsen et al. 2009). We 
expected an underestimation of the prevalence 
of in utero exposure to tobacco smoke in our 
sample because women who smoke as adults 
were more likely to report in utero exposure 
(data not shown). However, previous analy-
ses suggest that bias in the estimated param-
eters due to self-selection is negligible when 
evaluating exposure–outcome associations in 
the cohort (Nilsen et al. 2009); this tendency 
may hold when assessing early life exposures in 
  relation to adult outcomes.
Conclusion
Overall, self-reported in utero exposure to 
tobacco smoke was associated with obesity, 
hypertension, and GDM in adult women. 
The possibility that the associations were 
attributable to unmeasured confounding 
  cannot be excluded.
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